Benitec Biopharma Inc.
Benitec Biopharma Inc. (BNTC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BNTC · as of Sep 30, 2025
Ownership Breakdown
55
Institutional Holders
▼ 1 vs Q2
$324.73M
Total Inst. Value
▲ $59.42M vs Q2
26.25M
Shares Outstanding
freeFloat 96.05%
23.16M
13F Shares Held
▲ 469,769 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BNTC largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 9.88M | 27.28% | 27.28% | $138.57B | Nov 14, 2025 | — held |
JANUS HENDERSON GROUP PLC pharmaceutical preparations | 2.91M | 8.04% | 8.04% | $40.71B | Nov 14, 2025 | ▲ 8.9K |
FRANKLIN RESOURCES INC pharmaceutical preparations | 2.59M | 7.15% | 7.15% | $36.33B | Nov 13, 2025 | ▼ 111.8K |
ADAGE CAPITAL PARTNERS GP, L.L.C. pharmaceutical preparations | 1.97M | 5.45% | 5.45% | $27.67B | Nov 14, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 992.1K | 2.74% | 2.74% | $13.92B | Nov 7, 2025 | ▲ 22.9K |
BLACKROCK, INC. pharmaceutical preparations | 945.5K | 2.61% | 2.61% | $13.27B | Nov 12, 2025 | ▲ 226.8K |
NANTAHALA CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 838.1K | 2.31% | 2.31% | $11.76B | Nov 14, 2025 | — held |
INFINITUM ASSET MANAGEMENT, LLC pharmaceutical preparations | 500.0K | 1.38% | 1.38% | $7.01B | Nov 14, 2025 | — held |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 438.5K | 1.21% | 1.21% | $6.15B | Nov 12, 2025 | ▲ 23.3K |
SILVERARC CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 276.3K | 76.30% | 76.30% | $3.88B | Nov 12, 2025 | ▲ 23.0K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
26
Increased
+747.8K shares2
New Positions
first time holders9
Decreased
−160.7K shares0
Sold Out
fully exitedNet shares change (top 50)
+587.1K
+747.8K / −160.7K
Net new holders
+19
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BNTC insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Friedman David Matthew director | May 26, 2026 | Award | 35,000 | $11.45 | $400.8K | 35.0K | Form 4 ↗ |
Mates Sharon director | Jan 22, 2026 | Award | 31,500 | $12.83 | $404.1K | 31.5K | Form 4 ↗ |
SUVRETTA CAPITAL MANAGEMENT, LLC
| Dec 29, 2025 | Purchase | 65,800 | $13.44 | $884.4K | 9.70M | Form 4 ↗ |
SUVRETTA CAPITAL MANAGEMENT, LLC
| Dec 26, 2025 | Purchase | 14,320 | $13.10 | $187.6K | 9.63M | Form 4 ↗ |
SUVRETTA CAPITAL MANAGEMENT, LLC
| Dec 23, 2025 | Purchase | 42,600 | $12.85 | $547.4K | 9.62M | Form 4 ↗ |
SUVRETTA CAPITAL MANAGEMENT, LLC
| Dec 29, 2025 | Purchase | 11,587 | $13.44 | $155.7K | 1.85M | Form 4 ↗ |
SUVRETTA CAPITAL MANAGEMENT, LLC
| Dec 26, 2025 | Purchase | 2,516 | $13.10 | $33.0K | 1.84M | Form 4 ↗ |
SUVRETTA CAPITAL MANAGEMENT, LLC
| Dec 23, 2025 | Purchase | 7,400 | $12.85 | $95.1K | 1.83M | Form 4 ↗ |
SUVRETTA CAPITAL MANAGEMENT, LLC
| Dec 22, 2025 | Purchase | 16,650 | $12.08 | $201.1K | 9.58M | Form 4 ↗ |
SUVRETTA CAPITAL MANAGEMENT, LLC
| Dec 19, 2025 | Purchase | 13,950 | $11.48 | $160.1K | 9.56M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Benitec Biopharma Inc. (BNTC) is primarily owned by institutional investors, who hold approximately 88.2% of total shares outstanding. Company insiders own approximately 3.95%, while retail and public investors account for the remaining 7.82%.
The largest institutional shareholder of Benitec Biopharma Inc. is SUVRETTA CAPITAL MANAGEMENT, LLC, holding approximately 9.88 million shares — equal to 27.28% of outstanding shares — as of September 30, 2025.
A total of 55 institutional investors currently hold BNTC stock, with a combined institutional value of approximately $324,725,438 as of the most recent 13F filing period.
Frequently asked questions
BNTC ownershipBenitec Biopharma Inc. (BNTC) is primarily owned by institutional investors, who hold approximately 88.2% of shares. The largest shareholder is SUVRETTA CAPITAL MANAGEMENT, LLC with a 27.28% stake. Company insiders hold 3.95%. Data sourced from SEC Form 13F as of September 30, 2025.